SANDOZ INC FDA Approval ANDA 206144

ANDA 206144

SANDOZ INC

FDA Drug Application

Application #206144

Application Sponsors

ANDA 206144SANDOZ INC

Marketing Status

Discontinued001
Discontinued002

Application Products

001FOR SUSPENSION;ORAL100MG/5ML0CEFIXIMECEFIXIME
002FOR SUSPENSION;ORAL200MG/5ML0CEFIXIMECEFIXIME

FDA Submissions

UNKNOWN; ORIG1AP2017-11-17STANDARD

Submissions Property Types

ORIG1Null15

CDER Filings

SANDOZ INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206144
            [companyName] => SANDOZ INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"CEFIXIME","activeIngredients":"CEFIXIME","strength":"100MG\/5ML","dosageForm":"FOR SUSPENSION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"CEFIXIME","activeIngredients":"CEFIXIME","strength":"200MG\/5ML","dosageForm":"FOR SUSPENSION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/17\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-11-17
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.